What is Olatec Therapeutics?
Olatec Therapeutics is a privately held biopharmaceutical company dedicated to the clinical advancement of NLRP3 antagonist therapeutics. These treatments are designed to address a spectrum of inflammatory conditions, including arthritis, heart failure, and various forms of cancer. The company's lead compound, dapansutrile, has demonstrated clinical efficacy in mitigating systemic inflammation while maintaining a favorable safety profile. Olatec possesses a substantial pipeline comprising approximately 40 pharmaceutical candidates and a strong global intellectual property portfolio exceeding 180 patents. The company's leadership includes internationally recognized experts in inflammation and immunology, bolstering its drug development capabilities.
How much funding has Olatec Therapeutics raised?
Olatec Therapeutics has raised a total of $40M across 1 funding round:
Series A
$40M
Series A (2023): $40M with participation from Sanders Morris Harris and Advection Growth Capital
Key Investors in Olatec Therapeutics
Sanders Morris Harris
Sanders Morris Harris is a privately held financial services firm established in 1987, offering investment advisory, portfolio management, and financial planning services from its base in Houston, Texas.
Advection Growth Capital
Advection Growth Capital is a merchant bank specializing in investing in and advising high-growth companies, connecting family offices and institutional investors to facilitate growth and investment opportunities.
What's next for Olatec Therapeutics?
The substantial enterprise-level funding and recent strategic investment position Olatec Therapeutics for an accelerated growth trajectory. This capital infusion is anticipated to fuel the progression of its lead compound, dapansutrile, through further clinical trials and support the expansion of its extensive pipeline of nearly 40 pharmaceutical candidates. The company's focus on NLRP3 antagonist therapeutics targets a broad range of inflammatory diseases, indicating a strategic move to capture significant market share in a critical therapeutic area. Olatec's robust patent portfolio and experienced scientific leadership provide a strong foundation for future innovation and potential commercialization, signaling a promising outlook for the company's continued development and market impact.
See full Olatec Therapeutics company page
